Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone Perioperative Neuroprotection in Carotid Artery Stenosis
ChiCTR-OPC-17010767Phase 4Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of edaravone in carotid atheroma (CAS), sponsored by Shanghai Changzheng Hospital. Primary endpoints: Hyperperfusion syndrome, Secondary cerebral infarction and 5 more. Started Mar 2017; status: recruiting.
02
Drugs
edaravone
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ChiCTR-OPC-17010767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17010767.